DLB vs RTX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
DLB exhibits a dichotomy between exceptional financial health and poor growth momentum. The Piotroski F-Score of 8/9 indicates a very strong balance sheet with minimal debt (D/E 0.02) and high liquidity, yet the stock trades at a significant premium to its Graham Number ($38.84) and Intrinsic Value ($17.29). While the company maintains an elite gross margin of 87.86%, negative YoY revenue and earnings growth, coupled with bearish insider activity and a 0/100 technical trend, offset the strong fundamental health.
RTX exhibits stable financial health with a Piotroski F-Score of 5/9, yet it is trading at a severe premium compared to its Graham Number ($73.73) and Intrinsic Value ($96.67). While the company boasts an exceptional track record of earnings beats over 25 quarters and solid revenue growth, the valuation is stretched with a PEG ratio of 2.75. This fundamental overvaluation is compounded by bearish insider sentiment and a weak technical trend, suggesting that while the business is strong, the stock price is currently decoupled from its deterministic value.
Compare Another Pair
Related Comparisons
DLB vs RTX: Head-to-Head Comparison
This page compares Dolby Laboratories, Inc. (DLB) and RTX Corporation (RTX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.